Harmony Biosciences Holdings, Inc. (HRMY) has 20 known insider and institutional holders on record. The largest holder is Valor IV Pharma Holdings, LLC with 7,218,033 shares. Other notable holders include Marshman Fund Trust II and Wicki Andreas.
Over the last 12 months, insiders have made 34 transactions in HRMY stock — 15 buys (valued at $9.86M) and 6 sells (valued at $2.83M). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.
HRMY Insider Ownership
Top Holder
Valor IV Pharma Holdings, LLC
7,218,033 shares
Buys (12 mo)
15
$9.86M value
Sells (12 mo)
6
$2.83M value
12-Month Transaction Activity
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Valor Iv Pharma Holdings, Llc |
10 Percent Owner |
7,218,033 |
2024-11-05 |
|
| 2 |
Marshman Fund Trust Ii |
10 Percent Owner |
6,651,120 |
2024-11-05 |
|
| 3 |
Wicki Andreas |
Director |
2,154,393 |
2022-12-14 |
|
| 4 |
Aronin Jeffrey S |
Director |
1,180,599 |
2022-03-28 |
|
| 5 |
Anastasiou Peter |
Chief Operating Officer |
212,241 |
2026-04-06 |
|
| 6 |
Dayno Jeffrey M. |
President, CEO |
52,900 |
2026-01-26 |
|
| 7 |
Kapadia Sandip |
Chief Financial Officer |
24,521 |
2026-01-28 |
|
| 8 |
Ignelzi Troy A. |
Director |
17,710 |
2026-04-06 |
|
| 9 |
Zaeske Adam H. |
Chief Commercial Officer |
16,200 |
2026-01-26 |
|
| 10 |
Jacobs John C |
President, CEO |
15,197 |
2022-06-14 |
|
| 11 |
Szyper Linda M |
Director |
14,522 |
2025-05-16 |
|
| 12 |
Graf R. Mark |
Director |
14,522 |
2025-05-16 |
|
| 13 |
Sabater Juan A. |
Director |
14,522 |
2025-05-16 |
|
| 14 |
Gracias Antonio J. |
Director |
14,522 |
2025-05-16 |
|
| 15 |
Philip Ron M |
Director |
14,522 |
2025-05-16 |
|
| 16 |
Sender Gary |
Director |
14,522 |
2025-05-16 |
|
| 17 |
Dierks Jeffrey |
Chief Commercial Officer |
13,450 |
2025-01-28 |
|
| 18 |
Serafin Andrew |
Chief Strategy Officer |
12,200 |
2026-01-26 |
|
| 19 |
Budur Kumar |
Chief Medical Officer |
12,200 |
2026-01-26 |
|
| 20 |
Motley Eric L |
Director |
7,246 |
2021-06-14 |
|
Recent Transactions (last 12 months)
| Date |
Name |
Role |
Type |
Shares |
Price |
Value |
| 2026-04-02 |
Anastasiou Peter |
Chief Operating Officer |
RSU Award |
212,241 |
$27.74 |
$5.89M |
| 2026-04-02 |
Ignelzi Troy A. |
Director |
RSU Award |
17,710 |
$27.74 |
$491.28K |
| 2026-04-02 |
Ignelzi Troy A. |
Officer |
Unknown |
- |
- |
- |
| 2026-01-26 |
Kapadia Sandip |
Chief Financial Officer |
Informative Sell |
3,746 |
$37.15 |
$139.17K |
| 2026-01-22 |
Zaeske Adam H. |
Chief Commercial Officer |
RSU Award |
16,200 |
- |
- |
| 2026-01-25 |
Budur Kumar |
Chief Medical Officer |
Tax Withholding of RSU |
1,372 |
$36.82 |
$50.52K |
| 2026-01-24 |
Budur Kumar |
Chief Medical Officer |
Tax Withholding of RSU |
1,153 |
$36.82 |
$42.45K |
| 2026-01-22 |
Budur Kumar |
Chief Medical Officer |
RSU Award |
12,200 |
- |
- |
| 2026-01-25 |
Serafin Andrew |
Chief Strategy Officer |
Tax Withholding of RSU |
1,126 |
$36.82 |
$41.46K |
| 2026-01-24 |
Serafin Andrew |
Chief Strategy Officer |
Tax Withholding of RSU |
1,116 |
$36.82 |
$41.09K |
| 2026-01-22 |
Serafin Andrew |
Chief Strategy Officer |
RSU Award |
12,200 |
- |
- |
| 2026-01-25 |
Kapadia Sandip |
Chief Financial Officer |
Tax Withholding of RSU |
2,553 |
$36.82 |
$94K |
| 2026-01-24 |
Kapadia Sandip |
Chief Financial Officer |
Tax Withholding of RSU |
2,239 |
$36.82 |
$82.44K |
| 2026-01-22 |
Kapadia Sandip |
Chief Financial Officer |
RSU Award |
12,200 |
- |
- |
| 2026-01-25 |
Dayno Jeffrey M. |
President, CEO |
Tax Withholding of RSU |
5,654 |
$36.82 |
$208.18K |
| 2026-01-24 |
Dayno Jeffrey M. |
President, CEO |
Tax Withholding of RSU |
4,785 |
$36.82 |
$176.18K |
| 2026-01-22 |
Dayno Jeffrey M. |
President, CEO |
RSU Award |
52,900 |
- |
- |
| 2026-01-15 |
Kapadia Sandip |
Chief Financial Officer |
Informative Sell |
20,961 |
$35.92 |
$752.83K |
| 2025-12-12 |
Dayno Jeffrey M. |
President, CEO |
Informative Sell |
5,933 |
$40.11 |
$237.96K |
| 2025-12-05 |
Kapadia Sandip |
Chief Financial Officer |
Informative Sell |
20,000 |
$39.54 |
$790.9K |
| 2025-11-21 |
Kapadia Sandip |
Chief Financial Officer |
Informative Sell |
3,427 |
$35.00 |
$119.95K |
| 2025-09-30 |
Kapadia Sandip |
Chief Financial Officer |
Tax Withholding of RSU |
24,039 |
$27.56 |
$662.51K |
| 2025-08-28 |
Valor Iv Pharma Holdings, Llc |
10 Percent Owner |
Other (Sell) |
6,618,033 |
- |
- |
| 2025-08-15 |
Kapadia Sandip |
Chief Financial Officer |
Informative Sell |
21,573 |
$36.50 |
$787.38K |
| 2025-05-15 |
Philip Ron M |
Director |
RSU Award |
14,522 |
$34.23 |
$497.09K |
